https://www.prnewswire.com/es/comunicados-de-prensa/redhill-biopharma-receives-allowances-for-u-s-patent-applications-covering-opaganib-and-rhb-107-for-covid-19-864075994.html
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107...
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study...